This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

United HealthCare US antitrust case against Jazz over Xyrem dismissed after settlement

( July 16, 2025, 23:25 GMT | Official Statement) -- MLex Summary: Jazz Pharmaceuticals secured dismissal of United HealthCare Services's antitrust case over an alleged scheme to delay entry of a generic version of narcolepsy drug Xyrem, following a settlement between the parties. United had moved to voluntarily dismiss Jazz, and the claims are dismissed with prejudice, US District Judge Richard Seeborg of the Northern District of California said in his order.See attached file....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections